Infinity Pharmaceuticals | INFI - Market Capitalization


Infinity Pharmaceuticals reported $0 in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Alterity Therapeutics Limited AUD 40M 16M May/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Cipla INR 1.07T 85.24B May/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Eisai JPY 1.33T 22.44B May/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Incyte USD 21.73B 3B May/2026
Infinity Pharmaceuticals USD 0 0 Apr/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
Plus Therapeutics USD 71M 19M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 6.48B 1.18B May/2026